Transaction | Address | Amount |
---|---|---|
11b816...6664ba
|
THDeJy...SGH5wH
|
-
50.96 TRX
·
10.32 USD
|
11b816...6664ba
|
TEisVp...Te2gkZ
|
+
50.96 TRX
·
10.32 USD
|
eca3f7...f3b23e
|
TJjh5t...SDp2k3
|
-
0 TRX
·
0.00 USD
|
eca3f7...f3b23e
|
TM21u2...fcUrr6
|
+
0 TRX
·
0.00 USD
|
c17490...fb773d
|
TASB3u...ph6Rwa
|
-
0.000005 TRX
·
0.00 USD
|
c17490...fb773d
|
TDWWtd...m4tBd6
|
+
0.000005 TRX
·
0.00 USD
|
ede6a6...006d74
|
TXsPGv...BEiJM4
|
-
0 TRX
·
0.00 USD
|
ede6a6...006d74
|
TLLLLy...57kxJv
|
+
0 TRX
·
0.00 USD
|
8edc0c...75e5f8
|
TJGyzW...N14QCY
|
-
0 TRX
·
0.00 USD
|
8edc0c...75e5f8
|
TR7NHq...gjLj6t
|
+
0 TRX
·
0.00 USD
|
Tron Inc. shifts focus to a TRX-centered crypto treasury, registering $1 billion in securities.
Tron plans a $1 billion SEC filing, including a shelf registration. Here's why it matters.
Injective (INJ) targets $25 amid a bullish breakout attempt, hitting a five-month high of $16.35. Analysts predict a significant rally if key resistance levels are reclaimed. Still, failure to hold above certain thresholds might send prices down.